" class="no-js "lang="en-US"> Pfizer Archives - Medtech Alert
Saturday, March 25, 2023

Sort by:

Date

Top Post

Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer

Pfizer and Astellas Pharma have announced positive topline results from the Phase 3 EMBARK trial […]

Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

Pfizer has announced the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the […]

Pfizer Receives Potential FDA Approval for RSV Vaccine Candidate

Pfizer has announced that the US Food and Drug Administration’s (FDA) Vaccines and Related Biological […]

Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence

Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]

FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)

Pfizer has announced that the United States Food and Drug Administration (FDA) approved its supplemental […]

Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer

Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced […]

Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic Diseases

Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine-learning […]

New Partnership to Boost Research into Vaccines for Cancer

Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]

Pfizer Progresses its Oral Receptor into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity

Sosei Group Corporation, the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design […]

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more